Rising Survival Figure After Treatment to Boost the Bone Marrow Transplant Market


The worldwide market for bone marrow transplant will foresee a market growth owing to the increasing occurrences of anemia as well as blood cancers, increasing investing in logistic services, growing registries of bone marrow transplant and rising survival figure after treatment.

In addition, aspects for instance, growing per capita healthcare costs, technological advancements along with betterment in healthcare infrastructure are moreover likely to boost the overall market. This transplant generally concerns with the replacing of damaged or else diseased bone marrow with bone marrow stem cells or healthy tissue to treat various cases of anemia or blood cancer.

The worldwide market is anticipated to increase at a firm 3.9% CAGR all through assessment period 2015–2021 as well as will be evaluated at US$10.3 Billion in revenue terms towards 2021 end. However, region-wise, the European market will be dominant in volume and value terms all through the assessment period as a result of rising amount of bone marrow transplant centers along with increase in registry of bone marrow. The MEA regional market is highlighted to be foreseeing a sluggish expansion all through the assessment period moderately as a result of the comparatively lower existence of bone marrow transplant centers. Latin America regional market is likely to grow at robust 6.0% CAGR.

On the basis of stem cells or bone marrow, the transplant procedures include conventional bone marrow transplant or peripheral stem cell transplant (PSCT). The procedure types included in the overall market are allogeneic bone marrow transplant and autologous bone marrow transplant. The latter category will remain the dominating category in volume terms over the six years forecast period. Due to comparatively less concern of risks, the procedures of autologous bone marrow transplant are widely accepted at a higher rate.

However, there are various types of disease indication such as, lymphoma, leukemia, myelodysplasia, myeloma, thalassemia, aplastic anemia, myeloproliferative neoplasms, sickle cell anemia, solid tumors along with others. Of these, leukemia is considered to lead the market, capturing around 26.5% of the overall market share in revenue terms towards the end of 2021. The revenue share of thalassemia is anticipated to increase at the fastest 8.9% CAGR all through the assessment period.

In terms of the end users, the overall market is categorised into ambulatory surgical centers (ASC)multispecialty clinics and hospitals. Market players are required to set in motion innovative and advanced products to gain from the probable chances estimated to be generated by the worldwide market for bone marrow transplant.

The prominent market players manufacturing in the worldwide market are Merck Millipore Corporation, Lonza Group Ltd., AllCells LLC, Sanofi-Aventis LLC, American Type Culture Collection (ATCC) Inc and STEMCELL Technologies.

Visit More Information: https://www.persistencemarketresearch.com/samples/4288

Company: Persistence Market Research

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our offerings include pre-built reports that address every major sale, customized solutions to cater to client-specific needs, and consulting services to offer more value addition. Our next-generation research approach for exploring emerging technologies has allowed us to solve the most complex problems of clients. We do not follow a reactive approach, but a pro-active one. Expert analysts at PMR keep a tab on next-generation technologies in their R&D phase and provide the latest insights into these technologies when they are being commercialized. Our ground-breaking approach allows us to deliver market solutions before the technologies reach the market.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Send Enquiry for this story

By submitting this form you are giving a consent to HHMGlobal.com to store your submitted information.
See our Privacy Policy to learn more about how we use data.